United States News Todas as matérias

Merck (NYSE:MRK) agreed to acquire Silence Therapeutics (NASDAQ:SLN) for $20 per ADS, valuing its equity at approximately $1.3 billion.

Cytokinetics (NASDAQ:CYTK) received Health Canada approval for MYQORZO to treat adults with NYHA class II–III symptomatic obstructive hypertrophic cardiomyopathy, supported by 24-week trial results.

Mako Mining (NASDAQ:MAKO) recovered 12,743 ounces of gold in Q3 2026, generating approximately US$50 million in revenue from 11,581 ounces sold.

Chord Energy (NASDAQ:CHRD) reported preliminary third-quarter production of 290,500–290,900 barrels of oil equivalent daily, exceeding its guidance ceiling of 284,000 barrels.

AST SpaceMobile (NASDAQ:ASTS) welcomed a spectrum collaboration involving four European telecom operators, supporting its satellite connectivity strategy across a market exceeding 500 million subscribers.

Centrus Energy (NYSE:LEU) acquired Westerman Holdings for approximately $116 million, bringing manufacturing of centrifuge components into its operations.

EquipmentShare (NASDAQ:EQPT) raised its 2026 revenue forecast to $5.81–$6.05 billion, citing customer demand, fleet utilization and improving productivity.

EyePoint (NASDAQ:EYPT) announced plans to reduce its workforce by approximately 53%, targeting $30 million in annual savings following disappointing Phase 3 results.

Ardagh Group agreed to sell its approximately 42% stake in Trivium Packaging in a $3.4 billion transaction involving Silgan Holdings (NYSE:SLGN).

NRG Energy (NYSE:NRG) declared a quarterly cash dividend of $0.475 per common share, payable November 16, 2026, to shareholders of record November 2.

KKR (NYSE:KKR) agreed to sell Infinity Transportation to funds managed by Ares Management (NYSE:ARES) for approximately $2.9 billion in enterprise value.

CBIZ (NYSE:CBZ) reported third-quarter 2026 net income of $47 million, up 56.7%, as revenue increased 1.2% to $702 million.

Sunshine Silver Mining & Refining (NYSE:SSMR) completed approximately 47,600 meters of its 50,000-meter infill drilling program, advancing its planned Sunshine Mine restart in late 2028.

Fifth Third Bancorp (NYSE:FITB) reported third-quarter net income available to common shareholders of $828 million, with adjusted earnings reaching $1.13 per diluted share.

Biodesix (NASDAQ:BDSX) announced plans to develop an AI-powered lung nodule risk test with Vanderbilt University and Vanderbilt Health, targeting commercial availability in 2028.

BeOne Medicines (NASDAQ:ONC) announced presentations covering four investigational cancer therapies and seven TEVIMBRA abstracts at ESMO 2026 in Madrid.

Transocean (NYSE:RIG) announced two U.S. Gulf drilling contracts worth approximately $550 million in combined firm backlog for Deepwater Proteus and Deepwater Conqueror.

Perfect Corp (NYSE:PERF) received shareholder approval for its proposed $2-per-share merger with ProjectNY, securing approximately 99.99% of votes cast at its extraordinary general meeting.

Cleveland-Cliffs (NYSE:CLF) reported $612 million in third-quarter adjusted EBITDA, exceeding its $575 million guidance, as revenue reached $5.6 billion.

IDEAYA Biosciences (NASDAQ:IDYA) reported a 57% eye preservation rate in its OptimUM-09 trial, alongside updated darovasertib findings from two metastatic uveal melanoma studies.

Takeda (NYSE:TAK) reported a 67% lower relative risk of ulcerative colitis complications with ENTYVIO-based treatment targeting disease clearance rather than symptomatic remission alone.

Eli Lilly (NYSE:LLY) reported that Omvoh met its Phase 3 SHINE-2 primary endpoint, with 50% of 52 pediatric responders achieving clinical remission at Week 52.

Brent crude fell US$2.29, or 2.08%, to US$107.57 per barrel on Monday after Washington waived key Russia sanctions.

AbbVie (NYSE:ABBV) reported a 40.5% endoscopic remission rate at Week 24 for investigational ABBV-466 in its 300-patient Phase 2a TARGET-CD Crohn's disease trial.